Our drug administration technology enables routine administration to deliver drugs to specific back-of-eye tissues, including the suprachoroidal, sub-retinal, and other small spaces.
Our drug formulations are designed to suit the unique ocular environments into which they are delivered, resulting in better drug movement and therapeutic benefits. They provide effects lasting up to 12 months from a single administration.
If you would like to discuss a potential partnership with Oxular, working with either our device or drug formulation technologies, please contact us on the form below.
Oxular Limited, Magdalen Centre, 1 Robert Robinson Avenue, Oxford OX4 4GA, UK
Limited company registered in England and Wales (Registration No. 09331313) VAT No. GB 244 5883 81
Accessibility • Privacy and cookie policy • Conditions of use • Sitemap • Contact